Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.
Endoscopy. 2014 Feb;46(2):98-104. doi: 10.1055/s-0033-1344986. Epub 2014 Jan 29.
After radiofrequency ablation (RFA) of Barrett's esophagus, it may be difficult to determine whether complete eradication of intestinal metaplasia at the neosquamocolumnar junction (neo-SCJ) in the cardia has been achieved. It is claimed that narrow band imaging (NBI) may predict the presence of intestinal metaplasia, which would enable immediate treatment. The aim of the current study was to evaluate whether inspection of the neo-SCJ with NBI after RFA results in reliable detection of intestinal metaplasia.
Patients with a normal-appearing neo-SCJ who were scheduled for RFA were included in the study. Two expert endoscopists obtained images from the neo-SCJ in overview (high resolution white light and NBI mode) and from four areas using NBI zoom, followed by corresponding biopsies. Four other blinded expert endoscopists evaluated the images for the presence of intestinal metaplasia and type of mucosal pattern (round, small tubular, large tubular, villous). Endpoints were sensitivity and specificity for identifying patients and areas with intestinal metaplasia.
From 21 patients overview images from 21 neo-SCJs and NBI zoom images from 83 neo-SCJ areas were obtained. Intestinal metaplasia was present in five overview images (24 %) and nine zoom images (11 %). Using the overview images, sensitivity and specificity for identifying patients with intestinal metaplasia were 65 % (95 % confidence interval [CI] 38 - 86) and 46 % (95 %CI 33 - 60), respectively. For individual zoom images, sensitivity was 71 % (95 %CI 54 - 85) and specificity was 37 % (95 %CI 32 - 43).
After RFA, endoscopic inspection of the neo-SCJ with NBI in overview or zoom does not reliably predict presence or absence of intestinal metaplasia.
射频消融(RFA)治疗 Barrett 食管后,确定贲门处新的鳞柱状交界(neo-SCJ)的肠上皮化生是否完全消除可能具有一定难度。据称,窄带成像(NBI)可预测肠上皮化生的存在,从而可以立即进行治疗。本研究旨在评估 RFA 后检查 neo-SCJ 时使用 NBI 是否能可靠地检测出肠上皮化生。
纳入计划接受 RFA 治疗且 neo-SCJ 外观正常的患者。两名经验丰富的内镜医生分别使用高分辨率白光和 NBI 模式获得 neo-SCJ 的全景图像以及使用 NBI 放大技术获得 neo-SCJ 的四个区域的图像,然后进行相应的活检。另外四名盲法内镜医生评估图像中是否存在肠上皮化生以及黏膜模式(圆形、小管状、大管状、绒毛状)的类型。评估指标为识别存在肠上皮化生的患者和区域的敏感性和特异性。
共获得 21 例患者 21 个 neo-SCJ 的全景图像和 83 个 neo-SCJ 区域的 NBI 放大图像。在 5 个全景图像(24%)和 9 个放大图像(11%)中存在肠上皮化生。使用全景图像,识别存在肠上皮化生的患者的敏感性和特异性分别为 65%(95%置信区间 [CI] 38%至 86%)和 46%(95%CI 33%至 60%)。对于单个放大图像,敏感性为 71%(95%CI 54%至 85%),特异性为 37%(95%CI 32%至 43%)。
RFA 后,使用 NBI 对 neo-SCJ 进行内镜检查,无论是全景检查还是放大检查,都不能可靠地预测肠上皮化生的存在或不存在。